Price T Rowe Associates Inc Abbott Laboratories Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,050,501 shares of ABT stock, worth $470 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,050,501
Previous 4,062,475 0.29%
Holding current value
$470 Million
Previous $422 Million 9.4%
% of portfolio
0.05%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.07 - $118.13 $1.2 Million - $1.41 Million
-11,974 Reduced 0.29%
4,050,501 $462 Million
Q2 2024

Aug 14, 2024
SELL
$100.73 - $112.44 $7.52 Million - $8.4 Million
-74,697 Reduced 1.81%
4,062,475 $422 Million
Q1 2024

May 15, 2024
SELL
$109.52 - $120.96 $17.1 Million - $18.8 Million
-155,691 Reduced 3.63%
4,137,172 $470 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $4,419 - $5,409
-49 Reduced -0.0%
4,292,863 $473 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $3.06 Million - $3.67 Million
-32,026 Reduced 0.74%
4,292,912 $416 Million
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $22.1 Million - $24.6 Million
219,349 Added 5.34%
4,324,938 $472 Million
Q1 2023

May 15, 2023
SELL
$96.86 - $114.01 $16.5 Million - $19.5 Million
-170,712 Reduced 3.99%
4,105,589 $416 Million
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $566 Million - $664 Million
-5,950,387 Reduced 58.18%
4,276,301 $469 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $78.8 Million - $91.2 Million
813,894 Added 8.65%
10,226,688 $990 Million
Q2 2022

Aug 15, 2022
BUY
$102.07 - $123.37 $110 Million - $133 Million
1,074,432 Added 12.89%
9,412,794 $1.02 Billion
Q1 2022

May 16, 2022
BUY
$114.02 - $139.04 $304 Million - $370 Million
2,663,477 Added 46.93%
8,338,362 $987 Million
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $95.1 Million - $116 Million
-823,241 Reduced 12.67%
5,674,885 $799 Million
Q3 2021

Nov 15, 2021
SELL
$116.66 - $129.06 $257 Million - $284 Million
-2,199,778 Reduced 25.29%
6,498,126 $768 Million
Q2 2021

Aug 16, 2021
SELL
$105.79 - $124.53 $180 Million - $212 Million
-1,703,604 Reduced 16.38%
8,697,904 $1.01 Billion
Q1 2021

May 17, 2021
BUY
$108.84 - $128.23 $698 Million - $822 Million
6,413,312 Added 160.81%
10,401,508 $1.25 Billion
Q4 2020

Feb 16, 2021
BUY
$105.0 - $114.42 $419 Million - $456 Million
3,988,196 New
3,988,196 $437 Million

Others Institutions Holding ABT

# of Institutions
3,184
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email